WHO and ANRS Emerging Infectious Diseases strengthen their collaboration in the area of HIV, viral hepatitis and sexually transmitted infections

Dr Meg Doherty, Director of WHO’s Global HIV, Hepatitis and Sexually Transmitted Infections (STI) Programmes (WHO/HHS), and Professor Yazdan Yazdanpanah, Director of ANRS | Emerging infectious illnesses, signed a memorandum of understanding geared toward supporting
and strengthening their collaboration in analysis and data sharing to assist international well being coverage improvement and implementation in low- and middle-income nations (LMICs). The signature occurred on 27 June 2022, in Paris, throughout the annual
assembly of the worldwide community of the ANRS | Emerging infectious illnesses.

To strengthen the technical and strategic collaboration, WHO and the ANRS | Emerging Infectious Diseases signed a memorandum of understanding geared toward enhancing the scientific and technical cooperation between the 2 establishments in the area of HIV, hepatitis and STIs in low- and middle-income nations (LMICs), notably in west and central African nations,
in the following overarching areas:

• collectively evaluate analysis priorities for enhancing the prevention, remedy and care of HIV, hepatitis, and STIs and develop analysis packages and revolutionary approaches on recognized priorities;
• facilitate the implementation and adaptation of precedence analysis packages and revolutionary approaches by offering technical assist and strengthening human and technical capacities throughout ANRS-MIE networks, in explicit in LMICs the place analysis programmes
  are carried out; and
• promote info sharing: data sharing, dissemination, and switch of analysis outcomes to tell WHO international normative work, whereas supporting coverage and programmatic resolution making at nationwide stage, notably in ANRS-MIE accomplice nations.

The settlement was signed throughout the annual assembly of the Agency’s worldwide community – organized on 27 and 28 June 2022 at PariSanté Campus – which introduced collectively researchers from accomplice nations and France, institutional representatives
and associations, to current a listing of the analysis carried out in partnership with the LMICs and to determine the widespread work priorities on all of its themes. Dr Meg Doherty offered the new WHO international well being sector technique on HIV, hepatitis and STIs and
the alternatives for a strengthened partnership between the 2 establishments.

“Strengthening technical collaboration and analysis is an integral half of the global well being sector methods on, respectively, HIV, viral hepatitis and sexually transmitted infections for the interval 2022–2030, to information the
well being sector and speed up the implementation of focused strategic responses to realize the purpose of ending AIDS, viral hepatitis B and C and sexually transmitted infections by 2030,” stated Dr Meg Doherty. 

This first memorandum of understanding between WHO/HHS and ANRS | Emerging Infectious Diseases, takes place inside a framework settlement between the Government of France and WHO for a re-enforced partnership for the interval 2020–2025 that was signed
on 31 December 2019.

“The COVID-19 pandemic has highlighted the want to raised coordinate analysis on a worldwide scale and to contain French and worldwide companions in a dynamic of cohesion. Today, it’s important to grab this dedication and take it past the area
of emergence. The memorandum of understanding we’re signing immediately displays this mission, which goals in explicit to contribute to the targets of the third Sustainable Development Goal by 2030,” stated Professor Yazdan Yazdanpanah.

---

About ANRS | Emerging Infectious Diseases

ANRS | Emerging Infectious Diseases, based on 1 January 2021, is an autonomous company of Inserm whose missions are to facilitate, consider, coordinate and fund analysis into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis, and
rising and re-emerging infectious illnesses (rising respiratory illnesses, together with COVID-19, viral hemorrhagic fevers, arboviruses and many others.). 

Under the authority of the Ministry of Higher Education and Research and the Ministry of Health and Prevention, and directed by Professor Yazdan Yazdanpanah, ANRS | Emerging Infectious Diseases covers all areas of analysis: basic, scientific, public
well being, human and social sciences, putting the accent on innovation and the strengthening of worldwide partnerships.

With its One Health method centered on human well being, animal well being and human affect on the setting, the company is getting ready a response to the scientific challenges offered by rising illnesses and for the deployment of that response in instances of
disaster. 

The company federates and facilitates a quantity of nationwide and worldwide networks of researchers and medical doctors employed by the principal analysis organizations, universities, hospitals, and associations. Patient associations and civil society representatives
have a outstanding place inside the group of ANRS | Emerging infectious illnesses.